Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dimei Beauty Technology, commonly marketed as Dimyth, is a Guangzhou, China-based manufacturer of aesthetic and beauty equipment rather than a drug-development biotech company. The company develops, manufactures, and distributes commercial beauty and medical-aesthetic devices used by salons, spas, clinics, and distributors, with product categories spanning diode laser hair removal, IPL/SHR systems, HIFU, picosecond and Nd:YAG lasers, CO2 fractional laser, hydrafacial systems, and cryolipolysis/body contouring equipment. It also offers OEM and ODM manufacturing services and presents itself as an integrated provider covering R&D, production, and distribution. The business appears focused on non-invasive aesthetic procedures and export-oriented device sales rather than therapeutics, clinical drug pipelines, or molecular targets. For a biotech analyst, this should be classified as a commercial aesthetics device company in the broader healthcare/beauty-tech ecosystem, not a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dimei Beauty Technology.